Previous 10 | Next 10 |
home / stock / seovf / seovf news
(via TheNewswire) LONDON, ONTARIO - TheNewswire - June 15, 2020 - Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE:PSH), a clinical-stage regenerative medicine therapeutics company, is pleased to announce it has completed the acquisition of cellular local immune protection tec...
Sernova ( OTCQB:SEOVF +7.6% ) to acquire conformal coating cell encapsulation technology from Converge Biotech, accelerating expansion of its regenerative medicine therapeutics platform More news on: Sernova Corp., Healthcare stocks news, Merger & acquisition news, Re...
(via TheNewswire) L ondon, Ontario - TheNewswire - June 8, 2020 - Sernova Corp. (TSXV:SVA) (OTC:SEOVF)(FSE:PSH), a clinical-stage regenerative medicine therapeutics company, announced today its acquisition of an innovative cellular immune protection technology. This ...
(via TheNewswire) LONDON, ONTARIO - TheNewswire - June 3, 2020 - Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE:PSH ), a clinical-stage regenerative medicine therapeutics company, is pleased to announce that its submitted abstract entitled "Clinical Validation of the Implan...
(via TheNewswire) Sernova to utilize AgeX's UniverCyte TM gene technology to generate transplantable, universal immune-protected therapeutic cells for Sernova's Cell Pouch(TM) Platform ALAMEDA, California & LONDON, Ontario - TheNewswire - May 29, 20...
(via TheNewswire) LONDON, ONTARIO - TheNewswire - May 26, 2020 - Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE:PSH) (the "Corporation" or "Sernova") announces that the Board of Directors of the Corporation have considered current COVID-19 public health restrictions and dete...
(via TheNewswire) Sernova's Cell Pouch transplanted with Factor VIII corrected human cells shows robust functional blood clotting improvement demonstrating a novel first-in-class ex vivo gene therapy cell-based approach for the treatment of hemophilia A LONDON, ONTARI...
(via TheNewswire) L ondon, Ontario - TheNewswire - May 12, 2020 - Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE:PSH ), a clinical-stage regenerative medicine therapeutics company, is pleased to announce that the Horizon 2020 HemAcure Consortium will present scientific re...
(via TheNewswire) LONDON, ONTARIO - TheNewswire - April 27, 2020 - Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE:PSH) announced today, with its continued COVID-19 vigilance, social gathering size restrictions in effect imposed by public health authorities and the now anticipat...
(via TheNewswire) LONDON, ONTARIO - TheNewswire - April 21, 2020 - Sernova Corp. (TSXV:SVA)(OTC:SEOVF)(FSE:PSH), a clinical-stage regenerative medicine therapeutics company, announced today that it is implementing safety measures for its upcoming Annual Meeting of Sharehol...
News, Short Squeeze, Breakout and More Instantly...
(TheNewswire) LONDON, Ontario; BOSTON, Massachusetts – TheNewswire - July 15, 2024 – Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage biotechnology company focused on the development of regenerative medicine cell therapies for treatment o...
(TheNewswire) To date Sernova reports 7 patients in its Phase I/II type 1 diabetes clinical trial achieved freedom from insulin injections and demonstrate blood sugar control in the non- diabetic range (HbA1c 6.5%); 6 patients have reached between 5.5 and 50 months o...
(TheNewswire) LONDON, Ontario; BOSTON, Massachusetts – June 12, 2024 – TheNewswire – Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage biotechnology company focused on the development of regenerative medicine cell therapies for treatmen...